1. Prostaglandins
– Vaginal misoprostol is the most efficient prior to 28 weeks.
2. Oxytocin
– onset w/in 3-5 minutes and steady state w/in 40 minutes, gradual
increase in receptor sensitivity from 20-34 weeks -> plateau from 34
weeks until term -> then further increase, predictors of success =
BMI, dilation, parity, GA
a.
Low-dose: start
at 0.5-2 mU/min, increase by 1-2 mU/min every 15-40 minutes
b.
High-dose: start
at 6 mU/min, increase by 306 mU/min every 15-40 minutes
c.
NO maximum dose
established! (hypotension/hyponatremia with rapid infusions)
3.
Amniotomy –
insufficient evidence to support amniotomy alone for IOL, adding
AROM to Pitocin shortens induction-to-delivery interval, no evidence
to guide timing in GBS+ mothers
4.
Nipple
stimulation – useful in women with favorable cervices, decreases PPH
risk, trend towards increased perinatal death when unmonitored
5.
Membrane
stripping – increases phospholipase A2 and prostaglandin F2-alpha,
increases likelihood of delivery w/in 48 hours & decreases
likelihood of requiring other induction methods, may or may not
increase risk of PROM, insufficient data re: use in GBS+ mothers
Indications for Induction:
abruption, chorio, fetal demise, gHTN, cHTN, PreE, PROM, post-term
pregnancy, DM, renal disease, pulmonary disease, APLS, growth
restriction, isoimmunization, oligo, etc. (logistic reasons - risk
of rapid labor, distance from hospital, psychosocial issues - are
also acceptable) *success rate similar
to spontaneous labor if Bishop score 8+
-
Must confirm
term gestation if IOL being done for logistic/psychosocial reasons
o
Ultrasound prior
to 20 weeks supports GA >39 weeks
o
FHTs have been
present for 30+ weeks
o
It has been 36+
weeks since +UPT/SPT
-
Must discuss
risks of induction
o
In primigravidas
with unfavorable cervix, there is a 2-fold increase in C/S rate
o
Labor
progress/curve will be slower
-
Special cases
o
PROM: Oxytocin
reduced interval between ROM and delivery, reduced chorio, reduced
post-partum febrile morbility, reduced neonatal antibiotics…no
increase in C/S. Can also use prostaglandins. Insufficient evidence
re: mechanical dilators.
o
IUFD: Before 28
weeks, vaginal misoprostol 200-400 mcg q4-12h is preferred (even in
women with h/o C/S), but high-dose Pitocin is also acceptable. After
28 weeks, management is based on Bishop score (use Foley if cervical
ripening is needed and patient has a h/o C/S).
Contraindications to
Induction: previa, transverse lie, cord prolapse, prior classical
C/S or myomectomy that entered the cavity, active HSV, etc.